Differences in Health Care Expenditures by Cancer Patients During Their Last Year of Life: A Registry-Based Study
Higher costs are mainly related to lower age, higher frailty risk and having a hematological malignancy, and the effects are both statistically and clinically significant despite the fact that expensive drugs were not included. On the other hand, the costs were mainly comparable in regard to sex or socio-economic factors, indicating equal care.
Authors
- Peter Strang (ORCID: https://orcid.org/0000-0001-8514-5433)
- Max Petzold (ORCID: https://orcid.org/0000-0003-4908-2169)
- Torbjörn Schultz (ORCID: https://orcid.org/0000-0003-1619-4965)
- Linda Björkhem‐Bergman (ORCID: https://orcid.org/0000-0003-3505-9283)
Institutions
- Swedish Foundation for Strategic Research (SE)
- Karolinska Institutet (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Current Oncology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.3390/curroncol31100462
- Citations
- 6
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 6.78